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Hideki Yoshikawa1 and Norifumi Naka1*Abstract
Periosteal chondromas are rare benign cartilaginous tumors that arise adjacent to the cortex beneath the periosteum.
These lesions are usually slow-growing and rarely exceed 3 cm in the greatest dimension. Here, we describe a
17-year-old boy who had a giant periosteal chondroma of the right distal femur, which was treated with intralesional
resection and intensive curettage. In addition, we report a novel application of a bioresorbable plate in the
management of the large bone defect after resection of a benign bone tumor.
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Periosteal chondromas (juxtacortical chondromas) were
first described by Lichtenstein and Hall in 1952 [1]. They
are relatively uncommon, benign, hyaline cartilage tumors
that account for less than 2% of chondromas and are gener-
ally seen in men in their second and third decades of life
[2-6]. These lesions develop adjacent to the cortical surface
of bone beneath the periosteal membrane and often arise at
the metaphyses of long tubular bones, most commonly the
humerus followed by the femur and tibia [3-6]. They are
slow-growing tumors and usually smaller than 3 cm [7,8].
Here, we report a case of a giant periosteal chondroma
involving the right distal femur in a 17-year-old boy. We
treated this patient by intralesional resection and inten-
sive curettage, resulting in a large bone defect. We suc-
cessfully performed reconstruction of the defect using
interconnected porous calcium hydroxyapatite (IP-CHA)
and a bioresorbable plate.
Case presentation
A 17-year-old boy presented to our hospital with mild
pain in his right thigh, which he had experienced for the* Correspondence: nnaka@ort.med.osaka-u.ac.jp
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unless otherwise stated.previous month. The patient stated that 6 years earlier
he had hit this same thigh and felt pain and swelling at
that time. Then he visited the local doctor and a mass
on the anterior surface of his right distal femur was
revealed by plain radiographs. The symptoms gradually
decreased with time and he had received a follow-up
examination from the doctor. The patient had an other-
wise unremarkable past medical history.
At the first presentation to our clinic, physical examin-
ation revealed a firm, nontender mass with ill-defined
margins at the anterior aspect of his right thigh. The
mass was neither freely moveable nor adherent to the
skin. Range of motion was decreased at the right knee
joint. Plain radiographs showed that the lesion was
located on the anterior surface of the right distal femur
with cortical erosion, saucerization of the underlying
cortex, and a rim of sclerosis (Figure 1a,b). In addition,
computed tomography (CT) showed an extraskeletal
mass with focal calcification (Figure 2a,b). Magnetic res-
onance imaging (MRI) showed low intensity in the T1-
weighted image and high intensity in the T2-weighted
image (Figure 3a-d). The mass measured 8.9 cm long by
2.7 cm wide with a maximum height of 3.1 cm. The
mass did not appear to invade the intramedullary canal.
A preoperative diagnosis of periosteal chondroma or low-
grade (grade 1) periosteal chondrosarcoma was made. Astd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Preoperative plain radiographs. (a) Anteroposterior and (b) lateral radiographs showing cortical erosion, saucerization of the
underlying cortex, and a rim of sclerosis on the anterior surface of the right distal femur.
Imura et al. World Journal of Surgical Oncology 2014, 12:354 Page 2 of 7
http://www.wjso.com/content/12/1/354both of these tumors are frequently less aggressive than
high-grade (grade 2 or 3) chondrosarcomas, we elected to
perform intralesional resection and intensive curettage
after intraoperative pathological consultation instead of
biopsy.
We operated according to the preoperative surgical
plan. The tumor was well-circumscribed without inva-
sion into the muscle or subcutaneous tissue (Figure 4a).
Macroscopically, the periosteal tumor consisted of an
oval, well-circumscribed, cartilaginous tumor, measuring
9 × 3 × 3 cm in greater dimension (Figure 4b). An intra-
operative rapid pathological diagnosis of periosteal chon-
droma or low-grade periosteal chondrosarcoma wasFigure 2 Preoperative CT. (a) Sagittal and (b) axial scans, showing an ext
right distal femur.made. After resection and intensive curettage of the en-
tire lesion, we noted a large bone defect of the anterior
aspect of the distal femur (Figure 4c). We then grafted
IP-CHA (Neobone®; MMT Co. Ltd., Osaka, Japan) [9] to
the defect and covered it with a bioresorbable plate
(Super FIXSORB® MX Mesh; Takiron Co. Ltd., Osaka,
Japan) (Figure 4d). Histological examination of the resected
specimen showed a hyaline cartilage tumor arranged in a
lobular pattern and covered by periosteum without cyto-
logic atypia or mitosis (Figure 5a,b). The margins of the
mass were circumscribed, with no evidence of invasion or
permeation of adjacent structures. The final pathological
diagnosis was periosteal chondroma.raskeletal mass with focal calcification on the anterior surface of the
a b
c d
Figure 3 Preoperative MRI. (a) Sagittal and (b) axial T1-weighted images, showing a low-intensity mass on the anterior surface of the right
distal femur. (c) Sagittal and (d) axial T2-weighted images, showing a high-intensity mass. No evidence of marrow invasion was seen.
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he was discharged on postoperative day 14. Six months
after surgery, the range of motion in his right knee was
fully recovered and he returned to sports, including foot-
ball and baseball. Final radiographs revealed that particles
of IP-CHA were almost consolidated after the operation
(Figure 6a-d). There has been no sign of local recurrence
during the 12 months since the surgical resection.
Discussion
Benign and malignant periosteal chondroid tumors are
now recognized as distinct disease entities. The differen-
tial diagnosis to distinguish between periosteal chondro-
mas and periosteal chondrosarcomas is necessary for
avoiding aggressive and inappropriate treatment. There
are three fundamental radiographic features of periosteal
chondromas, including scalloping or remodeling of the
adjacent bony cortex, the presence of cartilaginous
matrix that appears as small dots and ringlets of cal-
cification, and a possible soft tissue mass component[8,10,11]. Although scalloping and sclerosis of the cortex
can be similar in the two lesions, periosteal chondrosar-
comas tend to invade the underlying bone, form no re-
active bone underlying the cortical lesion, and present a
large mass in the soft tissue [12]. In this case, imaging
features of the tumor were characteristic of a periosteal
chondroma but not of a periosteal chondrosarcoma.
It has been reported that the median size of periosteal
chondrosarcomas was considerably larger than that of
chondromas [7,8]. In this case, the size of the tumor was
approximately 9 cm in the longest diameter but had taking
more than 6 years to grow to this size, suggesting that the
tumor might be a giant periosteal chondroma rather than
a slow-growing low-grade periosteal chondrosarcoma.
In fact, the final pathological diagnosis was periosteal
chondroma.
Nevertheless, it is frequently difficult to differentiate
periosteal chondromas from low-grade periosteal chon-
drosarcomas. Wide excision is the treatment of choice in
high-grade chondrosarcomas but may result in increased
Figure 4 Intraoperative findings. (a) The tumor located on the anterior aspect of the right distal femur. (b) Macroscopic examination of the
specimen treated by intralesional resection and intensive curettage. (c) The large bone defect after resection of the tumor. (d) Appearance of the
lesion after reconstruction of the defect with IP-CHA and a bioresorbable plate.
Figure 5 Histology of the resected specimen (H & E stain). (a) Benign hyaline cartilage tumor covered with periosteum. Arrow heads
indicate the border between the lesion and the periosteum. (b) Hypocellular cartilage tumor without cytologic atypia and mitosis. Scale
bars: 100 μm.
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Figure 6 Postoperative plain radiographs. (a) Anteroposterior and (b) lateral postoperative routine radiographs showing the bone defect filled
with IP-CHA and covered with a bioresorbable plate. (c) Anteroposterior and (d) lateral radiographs at 12-month follow-up showing no local
recurrence of the tumor. Particles of IP-CHA were almost consolidated.
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for local recurrences and metastases in low-grade perios-
teal chondrosarcomas is extremely low, the necessity of a
wide margin is controversial for them [13-20]. Many au-
thors described that less extensive surgery was indicated
for low-grade chondrosarcomas, resulting in a good func-
tional outcome [15,19-21]. Conversely, the recommended
treatment for periosteal chondroma is intralesional or
marginal resection [4,6]. According to a literature review
of Lewis et al. [4], out of 165 cases of periosteal chondro-
mas, only six cases of local recurrence were reported, a
recurrence rate of 3.6%. Mora et al. [22] demonstrated
that the reported cases of local recurrence could beattributed to inadequate intralesional excision. No malig-
nant transformation, metastasis, or multiple lesions have
been reported. In the present case, intraoperative rapid
pathological diagnosis of periosteal chondroma or low-
grade periosteal chondrosarcoma was made and thus we
carried out intralesional resection and intensive curettage
to the entire lesion.
A large bone defect occurring after resection of the
tumor is frequently problematic. Recently, resorbable
bone devices have been developed [23,24]. Super FIX-
SORB MX® is a bioactive and totally resorbable osteo-
synthetic bone fixation device [24]. This device is made
from composites of unsintered hydroxyapatite particles
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unique compression forging process [24]. This device
has a modulus of elasticity close to that of natural cor-
tical bone and retains high strength during the period
required for bone healing [24-26]. It also shows optimal
degeneration, resorption behavior, and osteoconductiv-
ity, thus obviating the need for implant removal [24-27].
In addition, in this case, bone grafting alone was not suf-
ficient to reconstruct the bone defect and so we used a
bioresorbable plate to prevent particles of IP-CHA from
leaking out of the huge defect. The range of motion in
the knee was fully recovered, suggesting that the plate
did not cause severe adherence or tightness of the quad-
riceps femoris.
Bioresorbable bone devices have many potential appli-
cations in various clinical fields, such as craniofacial,
trauma, and spine surgery [27-29]. It has been reported
that seven patients with benign bony tumors of the an-
terior cranial vault and orbit underwent simultaneous
bony excision and reconstruction with alloplastic hard
tissue replacement implants [30]. However, to the best
of our knowledge, this is the first report of reconstruc-
tion of the large bone defect after removal of the perios-
teal chondroma arising in the long tubular bone using
synthetic bone grafts and a bioresorbable plate. This
novel reconstruction method should be effective for
large bone defects after resection and curettage of com-
mon benign bone tumors.
Conclusions
We present a case of a giant periosteal chondroma in
the right distal femur of a 17-year-old boy. We success-
fully treated the patient by intralesional resection and
intensive curettage of the tumor and performed recon-
struction of the large bone defect by grafting synthetic
bone grafts and using a bioresorbable plate.
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